Analysis of genetics and biomarkers for the development and progression of diabetic nephropathy using a multi-omics approach

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900025293

Enrollment

Unknown

Registered

2019-08-21

Start date

2017-03-01

Completion date

Unknown

Last updated

2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic nephropathy

Interventions

DN group+ non-DN group + healthy pepole group:N/A

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Diagnosed type 2 diabetic patients (DM), urinary albumin/creatinine ratio, serum creatinine and renal pathology with or without diabetic nephropathy (DN).

Exclusion criteria

Exclusion criteria: 1. Combined with serious cardiovascular, hepatic, hematopoietic diseases, etc.; 2. Receive immunosuppressive therapy (including glucocorticoids); 3. HIV positive; 4. Estimated survival period <1 year.

Design outcomes

Primary

Measure	Time frame
SCr;ACR;	—

Secondary

Measure	Time frame
HbA1c;Blood pressure;	—

Countries

China

Contacts

Public ContactFu Ping

West China Hospital of Sichuan University

fupinghx@163.com+86 18980601201

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026